DigitalDx Ventures
Venture capitalActively deployingSilicon Valley · Pre-Seed–Series A · 45 people tracked
Investment thesis
The firm believes that artificial intelligence combined with big data represents the future of personalized medicine. As medicine becomes increasingly data-driven and patient-specific, AI-powered diagnostic tools are essential to help clinicians interpret vast amounts of molecular and biological data—from genomes, microbiomes, and biomarkers—to enable earlier disease detection, more effective treatment selection, and better patient outcomes. The team has deep expertise in genomic testing, laboratory-developed tests, and clinical diagnostics, positioning it to identify and support companies creating breakthrough solutions in this space.
Source: firm website, verified Jul 21, 2026.
Team · 45 people
from the firm's websiteWhat they invest in
from 10 of 10 portfolio companiesDigital Health ×8AI & Machine Learning ×6Medical Devices ×6Biotech ×3Healthtech ×2Developer Tools ×1Hardware ×1Mental Health ×1
HQs:United States×3United Kingdom×1
Investments · 10 tracked
founders shown can be your intro pathOxford Cancer Analytics develops a diagnostic platform that combines proteomic measurement with AI to generate evidence-based clinical insights for lung disease management, initially focused on COPD and lung cancer.
AI & Machine LearningDigital HealthMedical DevicesOxford, GB
20/20 BioLabs develops AI-powered blood tests for early detection of multiple cancers and chronic diseases, using protein tumor markers and machine learning. The company offers affordable, at-home collection tests starting under $200, targeting individuals and healthcare providers seeking early disease detection.
BiotechDigital HealthHealthtechMaryland, US
Mr. Cohen(Founder, Chief Executive Officer, President)Dr. ZhouDr. Lebowitz(Chief Scientific Officer)
Biotia develops diagnostic tests and software for infectious disease detection using metagenomic sequencing and AI. The company serves patients, healthcare providers, and hospitals seeking pathogen identification and infection control intelligence.
AI & Machine LearningBiotechDigital Health
Delphi Diagnostics develops genomic diagnostic tests to personalize breast cancer treatment for healthcare providers. The company's Endocrine Activity Index measures endocrine transcriptional activity in early-stage hormone receptor-positive breast cancer to help optimize chemotherapy decisions and improve patient outcomes.
BiotechDigital HealthMedical Devices
GLX Analytix develops a blood test platform that measures glycocalyx fragments and uses AI/ML to create disease-specific biomarker signatures for diagnosing and monitoring brain diseases including neuropsychiatric, neurodegenerative, and autoimmune conditions. The company targets clinicians and healthcare providers seeking early detection and precision medicine insights for conditions like Parkinson's, multiple sclerosis, schizophrenia, and stroke.
AI & Machine LearningDigital HealthMedical Devices
Brian(Founder & CEO)
LifeWave develops an AI-powered system of care for chronic heart failure management that combines a non-invasive biomarker sensor measuring lung fluid with agentic AI to guide medication titration and therapy optimization. The platform is designed for use across diverse healthcare settings including homes, primary care, and remote monitoring to help patients and clinicians detect worsening heart failure early and reduce hospitalizations.
AI & Machine LearningDigital HealthMedical Devices
Neural Lab develops AirTouch, a gesture control and hand tracking software that works with any standard camera to enable touchless interaction with applications and devices. The solution maps hand gestures to mouse, keyboard, and touch inputs across operating systems without requiring custom hardware or software integration, serving industries including healthcare, manufacturing, retail, and enterprise.
AI & Machine LearningDeveloper ToolsHardwareSunnyvale, US
NOWDiagnostics develops point-of-care diagnostic testing solutions for healthcare providers and consumers. The company specializes in rapid diagnostic technologies in the medical device and testing sector.
Medical Devices
Lisa Nibauer(Chief Executive Officer)
Optina develops a retinal imaging and AI platform for diagnosing and managing Age-Related Macular Degeneration in eye care specialists and patients. The platform combines hyperspectral imaging technology with AI clinical decision support to improve early detection and disease monitoring.
AI & Machine LearningDigital HealthMedical Devices
Trayt Health is a technology platform for behavioral health state programs and health plans that coordinates care between primary care physicians and behavioral health providers. The platform enables early intervention services through workflow tools, measurement-based care coordination, and data analytics to track patient outcomes and program effectiveness.
Digital HealthHealthtechMental Health
Frequently asked questions
- What stage does DigitalDx Ventures invest at?
- DigitalDx Ventures invests at the Pre-Seed, Seed, Series A stages.
- What sectors does DigitalDx Ventures focus on?
- DigitalDx Ventures focuses on AI & Machine Learning, Digital Health, Medical Devices.
- Where is DigitalDx Ventures located?
- DigitalDx Ventures is headquartered in Silicon Valley, US.
Images
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.
An early-stage venture capital firm investing in technology founders building solutions across multiple sectors.